Disclosing conflicts of interest to research subjects: An ethical and legal analysis

Accountability in Research

Volumn 11, Issue 2, 2004, Pages 141-159

  Resnik, David B ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Biomedical research; Conflict of interest; Ethics; Informed consent; Institutional review boards; Jesse gelsinger; Legal liability

Indexed keywords

ARTICLE; BENEFICENCE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CONFLICT OF INTEREST; ECONOMICS; ETHICS; HUMAN; HUMAN RELATION; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; LEGAL APPROACH; LEGAL ASPECT; MEDICAL RESEARCH; PERSONAL AUTONOMY; PROFESSIONAL STANDARD; RESEARCH SUBJECT; TRUST;

BIOMEDICAL AND BEHAVIORAL RESEARCH; LEGAL APPROACH;

BENEFICENCE; BIOMEDICAL RESEARCH; CONFLICT OF INTEREST; DISCLOSURE; ETHICS COMMITTEES, RESEARCH; HUMANS; INFORMED CONSENT; PERSONAL AUTONOMY; RESEARCH SUBJECTS; RESEARCHER-SUBJECT RELATIONS; TRUST;

EID: 15844407526     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/03050620490512322     Document Type: Article

References (57)

1. Agnew, B. (2000). Financial conflicts get more scrutiny at clinical trials. Science 289: 1266-1267.
2. Areta v. Avedon, 858 P.2d 598 (Cal. 1993).
3. Association of American Universities (AAU). (2001). Report on Individual and Institutional Conflicts of Interest. New York: Author.
4. Association of American Medical Colleges (AAMC). 2002. Protecting Subjects, Preserving Trust, Promoting Progress II: Principles and Recommendations for Oversight of an Institution's Financial Interests in Human Research. Washington, D.C.: Author.
5. Barnes, M. (2002). Financial conflicts of interest in human subjects research: the problem of institutional conflicts. Journal of Law, Medicine, and Ethics 30: 390-399.
6. Benbow, S. (2003). Conflict + interest: Financial incentives and informed consent in human subject research. Notre Dame Journal of Law, Ethics, and Public Policy 17:181-215.
7. nd edition). New York: Oxford University Press.
8. th edition). (1999). St. Paul, MN: West Group.
9. Bok, S. (1978). Lying: Moral Choice in Public and Private Life. New York: Pantheon Books.
10. Canterbury v. Spence, 464 F.2d (D.C. Cir. 1972).
11. Cho, M. et al. (2000). Policies on faculty conflicts of interest at US universities. Journal of the American Medical Association 284:2203-2208.
12. Cobbs v. Grant, 104 Cal. Rptr. 505 (Cal. 1972).
13. Code of Federal Regulations. (1991). Title 45, Part 46, Subpart A.
14. Code of Federal Regulations. (1997). Title 21, Part 50.
15. DAB v. Brown, 570 N.W. 2d 168 (Minn. Ct. App. 1997).
16. DeAngelis, C. (2000). Conflict of interest and the public trust. Journal of the American Medical Association 284:2237-2238.
17. Department of Health and Human Services (DHHS). (2003). Financial relationships and interests in research involving human subjects: Guidance for human subject protection. Federal Register 68, 61 (March 31, 2003): 15456. Available at: http://ohrp.osophs.dhhs.gov/references/fr03-7691.pdf.
18. De Ville, K. (2002). The role of litigation in human research accountability. Accountability in Research 9:17-44.
19. Diamond, J., Levine, L., and Madden, M. (2000). Understanding Torts. New York: Lexis Publishing.
20. Foard v. Jarman, 387 S.E.2d 162 (N.C. 1990).
21. Friedberg, M. (1999). Evaluation of conflict of interest in economic analyses of new drugs used in oncology. Journal of the American Medical Association 282:1453-1457.
22. Gelsinger Complaint. (1999). Retrieved February 12, 2004 from http://www.sskrplaw.com/links/healthcare2.html
23. Greenberg v. Miami Children's Hospital, 264 F.Supp.2d 1064 (S.D. Fla. 2003)
24. Grimes v. Kennedy Krieger Institute, Inc., 782 A. 2d 807 (Md. 2001).
25. Hall, M., Ellman, I., and Strouse, D. (1999). Health Care Law and Ethics. St. Paul, MN: West Group.
26. Hamilton, R. (2000). The Law of Corporations. St. Paul, MN: West Group.
27. International Committee of Medical Journal Editors (ICMJE). (2003). Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Retrieved from http://www.icmje.org/.
28. Kass, N. et al. (1996). Trust, the fragile foundation of contemporary biomedical research. Hastings Center Report 26, 5:25-29.
29. Katz, J. (1984). The Silent World of Doctor and Patient. Baltimore: Johns Hopkins University Press.
30. Kim, S. et al. (2004). Potential research participants' views regarding researcher and institutional financial conflicts of interest. Journal of Medical Ethics 30: 73-79
31. Korn, D. (2000). Conflict of interest in biomedical research. Journal of the American Medical Association 284:2234-2237.
32. Krimsky, S. (2001). Journal policies on conflict of interest: If this is the therapy, what's the disease? Psychotherapy and Psychosomatics 70:115-117.
33. Krimsky, S. (2003). Science and the Private Interest. Lanham, MD: Rowman and Littlefield.
34. Lo, B. et al. (2000). Conflict-of-interest policies for investigators in clinical trials. New England Journal of Medicine 343: 1616-1620.
35. Marshall, E. (2000). Gene therapy on trial. Science 288:951-957.
36. McCary, V. et al. (2000). A national survey of policies on disclosure of conflicts of interest in biomedical research. New England Journal of Medicine 343:1621-1626.
37. Miller, T., and Horowitz, C. (2000). Disclosing doctors' incentives: Will consumers understand and value the information? Health Affairs 19:149-155.
38. Moore v. Regents of the University of California, 51 Cal.3d 120 (1990).
39. Morin, K. (1998). The standard of disclosure in human subject experimentation. Journal of Legal Medicine 19:157-221.
40. Morin, K. et al. (2002). Managing conflict of interest in the conduct of clinical trials. Journal of the American Medical Association 287:87-84.
41. Moses, H., and Martin, B. (2001). Academic relationships with industry: A new model for biomedical research. Journal of the American Medical Association 285:933-935.
42. Neade v. Portes, 303 Ill App 3d 799 (1999).
43. Public Health Services (PHS). (1995). Objectivity in research. Federal Register 60, 132 (11 July 1995): 35810-35819.
44. Richard, E., and Rathbrun, K. (1993). Law and the Physician. Boston: Little, Brown, and Company.
45. Resnik, D. (2004). Liability for institutional review boards: From accountability to lawsuits. The Journal of Legal Medicine 25: 131-184.
46. Resnik, D., and Shamoo, A. (2002). Conflict of interest and the university. Accountability in Research 9:45-64.
47. Rodwin, M. (1989). Physicians' conflicts of interest: The limitations of disclosure. New England Journal of Medicine 321: 1405-1408.
48. th edition). St. Paul, MN: West Group.
49. Shamoo, A. (1999). Institutional review boards (IRBs) and conflict of interest. Accountability in Research 7: 201-212.
50. Shamoo, A., and Resnik, D. (2003). Responsible Conduct of Research. New York: Oxford University Press.
51. Shimm, D. and Spece, R. (1991). Industry reimbursement for entering patients into clinical trials. Annals of Internal Medicine 115:148-151.
52. Sollitto, S. et al. (2003). Intrinsic conflicts of interest in research: A need for disclosure. Kennedy Institute of Ethics Journal 13, 2:83-91.
53. Stelfox, H. et al. (1998). Conflict of interest in the debate over calcium-channel agonists. New England Journal of Medicine 338:101-106.
54. Sugarman, J. et al. (1999). Empirical research on informed consent: An annotated bibliography. Hastings Center Report 29, 1:S1-S42.
55. Thompson, D. (1993). Understanding financial conflicts of interest. New England Journal of Medicine 329:573-576.
56. Veatch, R. (1987). The Patient as Partner: A Theory of Human Experimentation Ethics. Bloomington: Indiana University Press.
57. Woodward, B. 1999. Challenges to human subjects protections in U.S. medical research. Journal of the American Medical Association 282:1947-1952.